HHT is classified as an autosomal dominant disorder, and data from formal genetics have been confirmed by the demonstration of heterozygous mutations in three main genes: ACVRL1, ENG, and SMAD4. The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.